Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03182738 · ClinicalTrials.gov registry record · NA
Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03182738: Completed NA study, sponsored by Columbia University.
NCT03182738 is a NA study that has completed, run by Columbia University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03182738, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to use technology to improve symptom status and ultimately improve patient centered outcomes in people living with HIV/AIDS (PLWHA). The primary purpose of the intervention (VIP-HANA) is to improve symptom status. The investigators hypothesize that VIP-HANA will improve symptom frequency and intensity.
Primary Outcome
The Symptom Burden Score is an expanded version of the 20-item HIV symptom index. The score is calculated for the 28 most common symptoms in persons living with HIV. Each symptom is given a score ranging from 0 to 4 with the scores indicating the following: 0 (not experienced) , 1 (It doesn't bother me), 2 (It bothers me a little), 3 (It bothers me), or 4 (It bothers me a lot). The higher the score (closer to 4), the greater the symptom burden (worse outcome).
Interventions
- BEHAVIORAL VIP app without HIV-related symptom strategies.
- BEHAVIORAL VIP app that delivers HIV-related symptom strategies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-11-16 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
What the finished NCT03182738 record still lists
NCT03182738 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which VIP app without HIV-related symptom strategies. is the first listed.
NCT03182738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03182738 about?
NCT03182738 is a clinical study titled "Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms". The purpose of this study is to use technology to improve symptom status and ultimately improve patient centered outcomes in people living with HIV/AIDS (PLWHA). The primary purpose of the intervention (VIP-HANA) is to improve symptom status. The investigators hypothesize that VIP-HANA will improve ...
What is the current status of trial NCT03182738?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-11-16. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03182738?
The interventions under investigation include: VIP app without HIV-related symptom strategies. (BEHAVIORAL), VIP app that delivers HIV-related symptom strategies. (BEHAVIORAL).
Who is sponsoring clinical trial NCT03182738?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03182738's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI